We at the Cancer Epigenetics Society have lately focused our efforts on expanding the experimental datasets of the Cancer Epigenetics Drug Database with emphasis on three large classes of epigenetics-targeting drugs. These are the inhibitors of the DNA methyltransferases (DNMTi), histone deacetylases (HDACi), and histone methyltransferases (HMTi). Together, the three datasets include more than 2,500 [...]